My Gene Counsel
  • Labs & Precision Medicine
  • Health Systems & Clinical Partners
  • BIOPHARMA, CLINICAL TRIALS & PAYERS
  • Solutions
    • My Gene Screen
    • Living Lab Reports
    • Genetic Alerts
  • Media
    • Genetic Journal
    • News
    • Press Releases
    • Multimedia
    • Publications
    • Career Resources
    • Case Series
  • About Us
  • Login
Select Page
My Gene Counsel Quoted in Washington Post and Kaiser Health News

My Gene Counsel Quoted in Washington Post and Kaiser Health News

by Danielle Bonadies | Feb 9, 2021 | News

As seen on The Washington Post and Kaiser Health News By Christina Bennett When her gynecologist recommended genetic testing, Mai Tran was reluctant. “I didn’t really want to do it,” recalled Tran, who had just turned 21 and was living in New...
Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

by Danielle Bonadies | Jan 2, 2020 | News

In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...
Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

My Gene Counsel Weighs in on Large-Scale Multigene Panel Study of Hereditary Cancer Risk

by Danielle Bonadies | Sep 12, 2019 | News

Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk...
Precision Oncology News Features My Gene Counsel's New Report on Genetic Testing Errors

Precision Oncology News Features My Gene Counsel's New Report on Genetic Testing Errors

by Danielle Bonadies | Aug 24, 2019 | News

Errors in the ordering and interpretation of genetic tests for cancer, as well as in communicating results, are continuing to occur, and a newly published report highlighting some of these errors suggests that the nature of the mistakes are reflective of the rapid...
Genetic Testing: When Should You Consider Testing Beyond BRCA?

Genetic Testing: When Should You Consider Testing Beyond BRCA?

by Danielle Bonadies | May 17, 2019 | Multimedia

12Next >

Recent Posts

  • Genetic Testing Challenges in Precision Medicine: Lab Fails to Report NF2 Mosaic Variant
  • Career Compass: Tips and Tricks for Second Year Students and Recent Graduates with Christina Frater
  • Continuing Education Opportunities
  • ABGC Boards Resources
  • The Speed and Scope of Genetic Updates | My Gene Counsel

Archives

  • About Us
  • Media
  • Genetic Journal Blog
  • Labs & Precision Medicine
  • Health Systems & Clinical Partners
  • Biopharma, Clinical Trials & Payers
  • My Gene Screen
  • Living Lab Reports®
  • Genetic Alerts
  • Contact Us
  • FAQs
  • Career Resources

The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.

My Gene Counsel   ©